Unchaperoned examinations risk misconduct allegations

NewsGuard 100/100 Score

Doctors who continue performing intimate examinations unchaperoned risk allegations of misconduct, warn researchers in a letter to this week’s BMJ.

However, a recent study found that nearly half of male general practitioners never and rarely used chaperones when intimately examining women, while another found only 37% of general practitioners had a chaperoning policy.

The authors carried out a survey on patients’ preferences for chaperones at genitourinary medicine (GUM) clinics, where intimate examinations are routine.

A total of 252 patients took part in the survey during June and December 2003. Ninety two percent (232) were offered a chaperone before an intimate examination, 22% (52) accepted, 12% (27) expressed no preference, and 66% (153) declined.

Patients declined chaperones because they trusted the doctor, felt it unnecessary, wished privacy, felt embarrassed, or were not bothered.

Significantly fewer male patients accepted chaperones than female patients and significantly more female patients accepted chaperones from male doctors than from female doctors.

“Chaperones are there for the protection of both parties,” say the authors. “Perhaps further guidance will arise for other healthcare professionals, who until now may see patients unaccompanied.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.